ASCENDIS PHARMA A/S shareholders Q3 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 10,719,555$1,003,779,13019.76%
Q Global Advisors, LLC 285,000$26,68717.16%
Finepoint Capital LP 163,772$15,335,6107.64%
Avoro Capital Advisors LLC 3,670,000$343,658,8005.36%
Spyglass Capital Management LLC 614,618$57,552,8304.51%
Sofinnova Investments, Inc. 754,032$70,607,5564.45%
Saturn V Capital Management LP 112,473$10,531,9724.41%
DAFNA Capital Management LLC 136,212$12,754,8923.97%
ARS Investment Partners, LLC 285,918$26,773,3623.32%
Ghost Tree Capital, LLC 85,000$7,959,4002.62%
Resolute Capital Asset Partners LLC 37,500$3,5122.48%
WESTFIELD CAPITAL MANAGEMENT CO LP 3,802,177$356,035,8252.42%
Evolutionary Tree Capital Management, LLC 16,657$1,559,7612.01%
Matisse Capital 26,255$2,458,5181.74%
TimesSquare Capital Management, LLC 842,801$78,9201.23%
Affinity Asset Advisors, LLC 46,400$4,344,8961.22%
Nicholas Investment Partners, LP 170,609$15,975,8271.19%
Rock Springs Capital Management LP 425,500$39,843,8201.07%
RICE HALL JAMES & ASSOCIATES, LLC 169,787$15,898,8551.01%
Henry James International Management Inc. 24,495$2,293,7120.99%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q3 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.